Following up on these results, we then show that activation of Akt1, a central hub in the insulin pathway, alleviates long‐term memory decline and ameliorates altered anxiety levels in the APP/PS1 transgenic AD mouse model. This evidence concerns the gene AKT1 and Alzheimer disease.